Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Exploring Brazilin as a Potential Breast Cancer Therapy via Molecular Dynamics Simulation Targeting ERα, 17β-HSD1, and NUDT5 Receptors

VALENSI · Vol. ume No. 2 (2025) · hlm. 226–237

DOI
10.15408/jkv.v11i2.46465
ISSN
2548-3013, 2460-6065
Terbit
2025-11-30
Penerbit
Department of Chemistry, Faculty of Science and Technology Syarif Hidayatullah Jakarta State Islamic University
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Breast cancer remains one of the leading causes of cancer-related mortality worldwide, suggesting the need for novel therapeutic agents with greater efficacy and fewer side effects. Brazilin, a natural flavonoid compound isolated from Caesalpinia sappan L., has shown promising anticancer activity, particularly against breast cancer cells. This study explores the therapeutic potential of brazilin by evaluating its interactions with three key molecular targets: estrogen receptor alpha (ERα), 17β-hydroxysteroid dehydrogenase 1 (17β-HSD1), and Nudix hydrolase 5 (NUDT5). Using molecular dynamics (MD) simulations, the study assesses the stability and binding interactions of complex systems. The results indicate that brazilin forms a stable complex with ERα, demonstrated by a low RMSD (2.6 Å) and strong hydrogen bonding with Glu353, occupancies of 97.8%, and minimal flexibility at the binding site (average RMSF < 2.5 Å). The binding free energy (ΔG Total) for the ERα–brazilin complex was -54.28 kcal/mol, indicating a stronger affinity than the reference ligand 4-hydroxytamoxifen. Brazilin also showed favorable binding with 17β-HSD1 and NUDT5, with binding energies of -39.71 kcal/mol and -23.23 kcal/mol, respectively. These findings suggest that brazilin may modulate critical targets involved in breast cancer progression, particularly in hormone receptor-positive subtypes. Further experimental validation is necessary to confirm its efficacy and optimize its therapeutic potential.

Kata kunci

Jaringan kolaborasi para penulis

38 penulis · 161 tautan kepenulisan bersama · 58 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Universitas Airlangga
  • Sekolah Tinggi Farmasi Indonesia
  • National Research and Innovation Agency
  • University of San Carlos
  • Indonesia International Institute for Life Sciences
  • Universitas Bhakti Kencana
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Shinta KusumawardaniPadjadjaran University4
Muhammad YusufPadjadjaran University3
Toto SubrotoPadjadjaran University2
Khotibul UmamSekolah Tinggi Farmasi Indonesia2
Mia Tria NoviantiPadjadjaran University2
Clara ClaudiaAfiliasi tidak diketahui2
Elsa DestianaAfiliasi tidak diketahui2
Rista AwaliaAfiliasi tidak diketahui2
Taufik Ramdani TohariPadjadjaran University2
Arli Aditya ParikesitIndonesia International Institute for Life Sciences1
Viol Dhea KharismaUniversitas Airlangga1
Rima HandiyaniPadjadjaran University1
Idar IdarUniversitas Bhakti Kencana1
Neni NurainyPT Bio Farma (Indonesia)1
Muhammad YusufPadjadjaran University1
Yosua YosuaPadjadjaran University1
Elza Nurrachmanita SyafrudinPadjadjaran University1
Mufasirin MufasirinUniversitas Airlangga1
Kusnoto KusnotoUniversitas Airlangga1
Lucia Tri SuwantiUniversitas Airlangga1
Poedji HastutiekUniversitas Airlangga1
Endang SuprihatiUniversitas Airlangga1
Aswin Rafif KhairullahNational Research and Innovation Agency1
Yulianna PuspitasariUniversitas Airlangga1
Ikechukwu Benjamin MosesEbonyi State University1
Muhammad ‘Ahdi KurniawanUniversitas Airlangga1
Bima Putra PratamaNational Research and Innovation Agency1
Katty Hendriana Priscilia RiwuAfiliasi tidak diketahui1
Ahmad ZainuddinPadjadjaran University1
Adang FirmansyahAfiliasi tidak diketahui1
Deni DeniAfiliasi tidak diketahui1
Lina MaudyawatiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://journal.uinjkt.ac.id/index.php/valensi/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 10 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Exploring Brazilin as a Potential Breast Cancer Therapy via Molecular Dynamics Simulation Targeting ERα, 17β-HSD1, and NUDT5 Receptors</dc:title>
	<dc:creator xml:lang="en">Baroroh, Umi</dc:creator>
	<dc:creator xml:lang="en">Dasilva, Jasmine Aulia </dc:creator>
	<dc:creator xml:lang="en">Sundalian, Melvia </dc:creator>
	<dc:creator xml:lang="en">Astriany, Dewi </dc:creator>
	<dc:creator xml:lang="en">Ansori, Arif Nur Muhammad </dc:creator>
	<dc:creator xml:lang="en">Yee, Jonie C. </dc:creator>
	<dc:subject xml:lang="en">Brazilin</dc:subject>
	<dc:subject xml:lang="en">breast cancer</dc:subject>
	<dc:subject xml:lang="en">ERα</dc:subject>
	<dc:subject xml:lang="en">molecular dynamics simulation</dc:subject>
	<dc:subject xml:lang="en">NUDT5</dc:subject>
	<dc:subject xml:lang="en">17-β-HSD-1</dc:subject>
	<dc:description xml:lang="en">Breast cancer remains one of the leading causes of cancer-related mortality worldwide, suggesting the need for novel therapeutic agents with greater efficacy and fewer side effects. Brazilin, a natural flavonoid compound isolated from Caesalpinia sappan L., has shown promising anticancer activity, particularly against breast cancer cells. This study explores the therapeutic potential of brazilin by evaluating its interactions with three key molecular targets: estrogen receptor alpha (ERα), 17β-hydroxysteroid dehydrogenase 1 (17β-HSD1), and Nudix hydrolase 5 (NUDT5). Using molecular dynamics (MD) simulations, the study assesses the stability and binding interactions of complex systems. The results indicate that brazilin forms a stable complex with ERα, demonstrated by a low RMSD (2.6 Å) and strong hydrogen bonding with Glu353, occupancies of 97.8%, and minimal flexibility at the binding site (average RMSF &amp;lt; 2.5 Å). The binding free energy (ΔG Total) for the ERα–brazilin complex was -54.28 kcal/mol, indicating a stronger affinity than the reference ligand 4-hydroxytamoxifen. Brazilin also showed favorable binding with 17β-HSD1 and NUDT5, with binding energies of -39.71 kcal/mol and -23.23 kcal/mol, respectively. These findings suggest that brazilin may modulate critical targets involved in breast cancer progression, particularly in hormone receptor-positive subtypes. Further experimental validation is necessary to confirm its efficacy and optimize its therapeutic potential.</dc:description>
	<dc:publisher xml:lang="en">Department of Chemistry, Faculty of Science and Technology Syarif Hidayatullah Jakarta State Islamic University</dc:publisher>
	<dc:date>2025-11-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uinjkt.ac.id/index.php/valensi/article/view/46465</dc:identifier>
	<dc:identifier>10.15408/jkv.v11i2.46465</dc:identifier>
	<dc:source xml:lang="en">Jurnal Kimia Valensi; Jurnal Kimia VALENSI,  Volume 11, No. 2, November 2025; 226-237</dc:source>
	<dc:source>2548-3013</dc:source>
	<dc:source>2460-6065</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uinjkt.ac.id/index.php/valensi/article/view/46465/18404</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Umi Baroroh; Jasmine Aulia  Dasilva; Melvia  Sundalian, Dewi  Astriany, Arif Nur Muhammad  Ansori, Jonie C.  Yee</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>